Therefore, this study provides insight into the mechanism by which TR3 regulates AngII-induced pathological hypertrophy through its influence on mTOR signalling and reveals that TR3 may be a unique target for the treatment of clinical cardiac hypertrophy. Here, MTOR is linked to cardiac hypertrophy.